Literature DB >> 8425206

Adhesion of metastatic, ras-transformed NIH 3T3 cells to osteopontin, fibronectin, and laminin.

A F Chambers1, C Hota, C W Prince.   

Abstract

We previously reported that H-ras-induced metastatic ability in murine NIH 3T3 cells is accompanied by increased expression of osteopontin (OPN). OPN is a secreted phosphoprotein that contains a GRGDS amino acid sequence, suggesting adhesive function, but the function of OPN in tumor cells remains poorly understood. Here we report that PAP2 cells (ras-transformed, metastatic NIH 3T3 cells) adhere and spread on OPN-coated substrates, while NIH 3T3 cells adhere and spread poorly on OPN. A similar pattern was seen for adhesion to laminin, while both cell lines adhered equally well to fibronectin. Adhesive interactions to OPN, laminin, and fibronectin were specific and were blocked by GRGDS (but not control GRGESP) peptides. The kinetics of adhesion to all three substrates was examined. Maximum adhesion was observed at 30-60 min, with reduced adhesion thereafter. We also purified metabolically labeled [32P]OPN secreted by PAP2 cells. Labeled OPN bound better in solution to PAP2 cells than to NIH 3T3 cells, and binding to both cell lines was blocked by GRGDS peptides, results that are consistent with the adhesion and spreading of these cells to OPN-coated substrates. Malignant PAP2 cells thus not only secrete increased levels of OPN, relative to NIH 3T3 cells, but also adhere better to this protein. While the target of OPN secreted by tumor cells is not known, our results raise the possibility that tumor cells that secrete OPN may also bind this protein and that this binding may function in autocrine-type signal transduction important to malignancy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8425206

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  8 in total

1.  Osteopontin expression and distribution in human carcinomas.

Authors:  L F Brown; A Papadopoulos-Sergiou; B Berse; E J Manseau; K Tognazzi; C A Perruzzi; H F Dvorak; D R Senger
Journal:  Am J Pathol       Date:  1994-09       Impact factor: 4.307

2.  Macrophages express osteopontin during repair of myocardial necrosis.

Authors:  C E Murry; C M Giachelli; S M Schwartz; R Vracko
Journal:  Am J Pathol       Date:  1994-12       Impact factor: 4.307

3.  Extracellular matrix remodelling in myocardial hypertrophy and failure : focus on osteopontin.

Authors:  Pietro Francia; Arianna Uccellini; Alessandra Frattari; Anna Modestino; Agnese Ricotta; Cristina Balla; Ludovica Scialla; Massimo Volpe
Journal:  High Blood Press Cardiovasc Prev       Date:  2013-01-03

4.  Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer.

Authors:  A Bellahcène; V Castronovo
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

5.  Autocrine secretion of osteopontin by vascular smooth muscle cells regulates their adhesion to collagen gels.

Authors:  A S Weintraub; C M Giachelli; R S Krauss; M Almeida; M B Taubman
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

6.  The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro.

Authors:  L Liaw; M P Skinner; E W Raines; R Ross; D A Cheresh; S M Schwartz; C M Giachelli
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

7.  Adhesive properties of osteopontin: regulation by a naturally occurring thrombin-cleavage in close proximity to the GRGDS cell-binding domain.

Authors:  D R Senger; C A Perruzzi; A Papadopoulos-Sergiou; L Van de Water
Journal:  Mol Biol Cell       Date:  1994-05       Impact factor: 4.138

8.  Osteopontin is required for full expression of the transformed phenotype by the ras oncogene.

Authors:  Y Wu; D T Denhardt; S R Rittling
Journal:  Br J Cancer       Date:  2000-07       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.